Royal Bank of Canada Lowers Sandoz Group (OTCMKTS:SDZNY) to Hold

Royal Bank of Canada cut shares of Sandoz Group (OTCMKTS:SDZNY) from a moderate buy rating to a hold rating in a research report released on Monday morning, Zacks.com reports.

Sandoz Group Trading Down 0.4 %

Shares of OTCMKTS SDZNY opened at $40.78 on Monday. Sandoz Group has a 1 year low of $25.71 and a 1 year high of $44.98. The firm’s 50-day moving average is $41.75 and its 200-day moving average is $36.43. The company has a quick ratio of 0.86, a current ratio of 1.33 and a debt-to-equity ratio of 0.49.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.